Affiliation:
1. Department of Pharmacy Practice , Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University , B G Nagara , Karnataka , , India
2. Department of Otorhinolaryngology and Head & Neck Surgery , Adichunchanagiri University , B G Nagara , Karnataka , , India
Abstract
Abstract
CAUTIs (catheter-associated urinary tract infections) continue to be one of the most common health-care-related illnesses in the entire globe. CAUTIs are the cause of 40% of all hospital-acquired infections and 80% of all nosocomial urinary tract infections (UTIs). A urine catheter is implanted into a high percentage of inpatients at some point during their hospitalization, and indwelling urinary catheter adoption likely to be on the rise. Urinary catheters, made of plastic materials, inhibit the urinary tract’s natural defence mechanisms and enhance the bacterial colonization or biofilm formation on the catheter surface, which may cause CAUTIs. It is associated with increased burden of disease, mortality, hospital bills and length of hospital stay. Therefore, to prevent these infections, technological innovations in catheter materials that limit biofilm formation will be required. Unfortunately, many health-care practitioners are unclear of the precise indications for bladder catheterization and accurate CAUTI criteria, which can lead to unnecessary catheterization, antibiotic overuse for asymptomatic bacteriuria and the spread of resistant organisms. As a result, we discuss CAUTIs in general, including definitions, pathophysiology, causation, indications for catheterization and a variety of effective CAUTI-fighting strategies.
Subject
Drug Discovery,Pharmacology,General Medicine,Physiology
Reference41 articles.
1. Nicolle, LE. Catheter associated urinary tract infections. Antimicrob Resist Infect Control 2014;3:1–8. https://doi.org/10.1186/2047-2994-3-23.
2. Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–40. https://doi.org/10.1016/0196-6553(88)90053-3.
3. National healthcare safety network (NHSN) patient safety component manual. Centers for Disease Control and Prevention website. (CDC); January 2019. file:///C:/Users/admin/Downloads/cdc_61568_DS1.pdf.
4. Magill, S, O’Leary, E, Janelle, S, Thompson, D, Duymati, G, Nadle, J, et al.. Changes in prevalence of health care associated infection in the U.S. hospitals. N Engl J Med 2018;379:1732–44. https://doi.org/10.1056/nejmoa1801550.
5. Chapple, C, Overview on the lower urinary tract. In: Andersson K, Michel M, editors. Handbook of experimental pharmacology. Heidelberg, Berlin, Germany: Springer; 2011, vol 2011.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献